Primus In News
Precision oncology gains ground as India clears targeted cancer therapies
25-12-2025
Nilaya Varma, Group CEO and Co-Founder,Primus Partners, highlights that the approvals represent a major step toward integrating outcome-based precision medicine into routine cancer care, with combination immunotherapies improving treatment outcomes for patient groups that previously had limited options.
Explore Related Insights
- How India is trying to balance innovation and safety in its AI governance structure
- Can the Foxconn-HCL wafer-level packaging project put India on the global semiconductor map?
- Andhra Pradesh constitutes Data Centre Advisory Council
- ICC World Cup: Where does women’s cricket stand after historic win?
